Join us to discuss what health system leaders and companies have learned during the rapid roll-out of new technologies during COVID-19. What’s worked well? What’s here to stay? And where is there opportunity for improvement?


What protocols and systems did practice managers and health system administrators make or change to meet the needs of COVID-19 patients and still care for existing patients?


Good morning everyone and welcome to our virtual panel discussion! The COVID-19 Pandemic created a need for a rapid rollout of solutions to address new challenges over the past year. What were some key takeaways for both health systems and companies?

We were fortunate to invest in telehealth 6 years prior to pandemic. Extensive handholding and rollout to ensure success. No one anticipated the importance "back then"
I agree @Adam. The best successes were with platforms already in the systems but expanded to meet the needs; from patient engagement to virtual ICU and beyond.
Agreed @Adam and @Emily. The systems that had emphasized investment, implementation, and development of a strategic innovation framework were able to absorb and/or deploy new solutions and capabilities faster. Unfortunately, it was a big wake up call for many health systems who thought they had these things in place but actually did not.
Pending
From my perspective, the most impressive feat was the redeployment of non-clinical personnel in an all-hands-on-deck effort to care for all patients while maintaining their usual duties and keeping the overall ship afloat. In addition, I also want to acknowledge the nurses and other clinical personnel that were quickly mobilized to travel to the front lines to combat COVID-19. The collective effort of all of these individuals is nothing short of incredible.
Pending
As most are aware, the Emergency Departments of New York were very stressed during the pandemic. During this time there was an increased need for sharing data so that hospitals and EDs could coordinate care. This trend has seemed to hold now being on the tail end of the pandemic which will likely benefit many innovations and research in the future.